APPLICATION
ANDA065502
TYPE
ANDA
ORIGINAL APPROVAL
2010-09-21
LATEST ACTION
2015-11-25
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription
Products
RIFAMPINPrescription
RIFAMPIN 600MG/VIAL · INJECTABLE · INJECTION
Approval history
2015-11-25Labeling · Supplement 2 · standardAP
2012-04-18Labeling · Supplement 1AP
2010-09-21OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.